Lynx DX Inc.
Ann Arbor, MI
- UEI
- CVMDCVXNU3K1
- CAGE
- 8EWM7
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5230 S State Rd, Ann Arbor, MI 48108, USA
- Website
- lynxdx.com
- Founded
- 2015
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Urine diagnostic tool for the detection of high-grade prostate cancer | National Cancer Institute (NIH) | $3,990,296 |
Quick answers
Is Lynx DX Inc. registered in SAM.gov?
Yes. Lynx DX Inc.'s SAM.gov registration is active through June 18, 2027.
What is Lynx DX Inc.'s most recent federal award?
Lynx DX Inc.'s most recent federal grant award is Urine diagnostic tool for the detection of high-grade prostate cancer (R44CA254692), from National Cancer Institute (NIH), on September 1, 2020.
On GovTribe
See Lynx DX Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors